Rigel Pharmaceuticals Inc (RIGL.OQ)

RIGL.OQ on NASDAQ Stock Exchange Global Select Market

1.71USD
22 Oct 2014
Price Change (% chg)

-- (+0.00%)
Prev Close
$1.71
Open
$1.71
Day's High
$1.75
Day's Low
$1.57
Volume
256,957
Avg. Vol
213,315
52-wk High
$5.00
52-wk Low
$1.57

RIGL.OQ

Chart for RIGL.OQ

About

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Its research focuses on intracellular signaling pathways and related targets that are critical to disease... (more)

Overall

Beta: 1.26
Market Cap (Mil.): $150.13
Shares Outstanding (Mil.): 87.79
Dividend: --
Yield (%): --

Financials

  RIGL.OQ Industry Sector
P/E (TTM): -- 152.31 33.65
EPS (TTM): -1.01 -- --
ROI: -41.53 -1.40 17.48
ROE: -43.03 -6.49 18.31
Search Stocks

Rigel eye drug fails mid-stage study, shares fall

- Rigel Pharmaceuticals Inc said it would stop testing its drug for some patients with dry eye disease after the treatment failed a mid-stage study.

13 Aug 2014

UPDATE 2-Rigel eye drug fails mid-stage study, shares fall

Aug 13 - Rigel Pharmaceuticals Inc said it would stop testing its drug for some patients with dry eye disease after the treatment failed a mid-stage study.

13 Aug 2014

Rigel experimental eye drug fails mid-stage study

Aug 13 - Rigel Pharmaceuticals Inc said its experimental drug failed to meet the main goal in a mid-stage study in patients with dry eye disease.

13 Aug 2014

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF85.00 +0.35
Roche Holding Ltd. (ROG.VX) CHF278.20 -0.10
Merck & Co., Inc. (MRK.N) $56.42 +0.91
Sanofi SA (SASY.PA) €84.21 +0.78
AstraZeneca plc (AZN.L) 4,305.00p -11.50
Abbott Laboratories (ABT.N) $42.24 +0.65

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks